Shuttle Pharmaceuticals Holdings, Inc. (SHPH)

NASDAQ: SHPH · Real-Time Price · USD

0.6892

-0.0167 (-2.37%)

At close: May 8, 2026, 4:00 PM EDT

0.6638

-0.0254 (-3.69%)

After-hours: May 8, 2026, 7:59 PM EDT

Company Description

Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers.

It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development.

The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.

Shuttle Pharmaceuticals Holdings, Inc.

Country	United States
Founded	2012
IPO Date	Aug 31, 2022
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	2
CEO	Christopher Cooper

Contact Details

Address: 401 Professional Drive, Suite 260 Gaithersburg, Maryland 20879 United States
Phone	240 403 4212
Website	shuttlepharma.com

Name	Position
Christopher Robert Cooper BBA, M.B.A.	Interim Chief Executive Officer and Director
Dr. Milton Brown CSC, M.D., Ph.D.	Co-Founder
Dr. Mira Jung Ph.D.	Co-Founder and Chief Scientific Officer for Biology
Dr. Tyvin A. Rich M.D.	Chief Clinical Officer and Chief Medical Officer
Michael P. Vander Hoek	Vice President for Operations and Regulatory

Date	Type	Title
May 7, 2026	8-K	Current Report
May 1, 2026	8-K	Current Report
Apr 20, 2026	ARS	Filing
Apr 20, 2026	DEF 14A	Other definitive proxy statements
Apr 10, 2026	PRE 14A	Other preliminary proxy statements
Mar 31, 2026	10-K	Annual Report
Mar 10, 2026	8-K	Current Report
Mar 9, 2026	424B3	Prospectus
Feb 17, 2026	EFFECT	Notice of Effectiveness
Feb 17, 2026	8-K	Current Report